Delayed clearance of Pneumocystis carinii infection, increased inflammation, and altered nitric oxide metabolism in lungs of surfactant protein-D knockout mice

Journal of Infectious Diseases

Volumn 189, Issue 8, 2004, Pages 1528-1539

  Atochina, Elena N ^a   Gow, Andrew J ^b   Beck, James M ^c   Haczku, Angela ^a   Inch, Adam ^a   Kadire, Helchem ^a   Tomer, Yaniv ^a   Davis, Christine ^b   Preston, Angela M ^c   Poulain, Francis ^d   Hawgood, Samuel ^d   Beers, Michael F ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 NITROTYROSINE; CD4 ANTIGEN; INDUCIBLE NITRIC OXIDE SYNTHASE; LUNG SURFACTANT; NITRIC OXIDE; SURFACTANT PROTEIN D;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; FEMALE; INFLAMMATION; INOCULATION; KNOCKOUT MOUSE; LUNG; LUNG ALVEOLUS CELL; LUNG WEIGHT; MALE; METABOLISM; MOUSE; NONHUMAN; PNEUMOCYSTIS CARINII; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; WILD TYPE;

ANIMALS; BLOTTING, NORTHERN; BRONCHOALVEOLAR LAVAGE FLUID; FEMALE; HISTOCYTOCHEMISTRY; LUNG; LYMPHOCYTE DEPLETION; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; PNEUMOCYSTIS CARINII; PNEUMONIA, PNEUMOCYSTIS; PULMONARY SURFACTANT-ASSOCIATED PROTEIN D; PULMONARY SURFACTANTS; RNA, BACTERIAL; SPECIFIC PATHOGEN-FREE ORGANISMS; TYROSINE;

EID: 11144354728     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/383130     Document Type: Article

References (59)

1. Levine SJ. Pneumocystis carinii. Clin Chest Med 1996; 17:665-75.
2. Hughes WT. Current issues in the epidemiology, transmission, and reactivation of Pneumocystis carinii. Semin Respir Infect 1998; 13:283-8.
3. Roblot F, Godet C, Le Moal G, et al. Analysis of underlying diseases and prognosis factors associated with Pneumocystis carinii pneumonia in immunocompromised HIV-negative patients. Eur J Clin Microbiol Infect Dis 2002; 21:523-31.
4. Russian DA, Levine SJ. Pneumocystis carinii pneumonia in patients without HIV infection. Am J Med Sci 2001; 321:56-65.
5. Limper AH. Alveolar macrophage and glycoprotein responses to Pneumocystis carinii. Semin Respir Infect 1998; 13:339-47.
6. Beck JM, Harmsen AG. Lymphocytes in host defense against Pneumocystis carinii. Semin Respir Infect 1998; 13:330-8.
7. Crouch E, Hartshorn K, Ofek I. Collecting and pulmonary innate immunity. Immunol Rev 2000; 173:52-65.
8. Weaver TE, Conkright JJ. Functions of surfactant proteins B and C. Annu Rev Physiol 2001; 63:555-78.
9. Hawgood S, Poulain FR. The pulmonary collectins and surfactant metabolism. Annu Rev Physiol 2001; 63:495-519.
10. Crouch EC, Wright JR. Surfactant proteins A and D and pulmonary host defense. Annu Rev Physiol 2001; 63:521-54.
11. Akiyama J, Hoffman A, Brown C, et al. Tissue distribution of surfactant proteins A and D in the mouse. J Histochem Cytochem 2002; 50:993-6.
12. Crouch EC. Structure, biologic properties, and expression of surfactant protein D (SP-D). Biochimica et Biophysica Acta 1998; 1408:278-89.
13. Botas C, Poulain F, Akiyama J, et al. Altered surfactant homeostasis and alveolar type II cell morphology in mice lacking surfactant protein D. Proc Natl Acad Sci USA 1998; 95:11869-74.
14. Korfhagen TR, Sheftelyevich V, Burhans MS, et al. Surfactant protein-D regulates surfactant phospholipid homeostasis in vivo. J Biol Chem 1998; 273:28438-43.
15. Madan T, Eggleton P, Kishore U, et al. Binding of pulmonary surfactant proteins A and D to Aspergillus fumigatus conidia enhances phagocytosis and killing by human neutrophils and alveolar macrophages. Infect Immun 1997; 65:3171-9.
16. Borron PJ, Crouch EC, Lewis JF, Wright JR, Possmayer F, Fraher LJ. Recombinant rat surfactant-associated protein D inhibits human T lymphocyte proliferation and IL-2 production. J Immunol 1998; 161: 4599-603.
17. Yoshida M, Korfhagen TR, Whitsett JA. Surfactant protein D regulates NF-κB and matrix metalloproteinase production in alveolar macrophages via oxidant-sensitive pathways. J Immunol 2001; 166:7514-9.
18. Clark H, Palaniyar N, Strong P, Edmondson J, Hawgood S, Reid KBM. Surfactant protein D reduces alveolar macrophage apoptosis in vivo. J Immunol 2002; 169:2892-9.
19. Reid KB. Functional roles of the lung surfactant proteins SP-A and SP-D in innate immunity. Immunobiology 1998; 199:200-7.
20. Brinker KG, Martin E, Borron P, et al. Surfactant protein D enhances bacterial antigen presentation by bone marrow-derived dendritic cells. Am J Physiol Lung Cell Mol Physiol 2001; 281:L1453-63.
21. Zimmerman PE, Voelker DR, McCormack FX, Paulsrud JR, Martin WJ 2nd. 120-kD surface glycoprotein of Pneumocystis carinii is a ligand for surfactant protein A. J Clin Invest 1992; 89:143-9.
22. Vuk-Pavlovic Z, Standing JE, Crouch EC, Limper AH. Carbohydrate recognition domain of surfactant protein D mediates interactions with Pneumocystis carinii glycoprotein A. Am J Respir Cell Mol Biol 2001; 24: 475-84.
23. Von Iwarden FB, Welmers J, Verhoef HP, Haagsman HP, van Golde LMG. Pulmonary surfactant protein A enhances host defense mechanism of alveolar macrophages. Am J Respir Cell Mol Biol 1990; 2:91-3.
24. Limper AH, Crouch EC, O'Riordan DM, et al. Surfactant protein-D modulates interaction of Pneumocystis carinii with alveolar macrophages. J Lab Clin Med 1995; 126:416-22.
25. Linke MJ, Harris CE, Korfhagen TR, et al. Immunosuppressed surfactant protein A - deficient mice have increased susceptibility to Pneumocystis carinii infection. J Infect Dis 2001; 183:943-52.
26. Wright JR. Immunomodulatory functions of surfactant. Physiol Rev 1997; 77:931-62.
27. Beckman JS, Koppenol WH. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and the ugly. Am J Physiol 1996; 271:C1424-37.
28. van der Vliet A, Eiserich JP, Shigenaga MK, Cross CE. Reactive nitrogen species and tyrosine nitration in the respiratory tract. Am J Respir Crit Care Med 1999; 160:1-9.
29. Matthay MA, Geiser T, Matalon S, Ischiropoulos H. Oxidant-mediated lung injury in the acute respiratory distress syndrome. Crit Care Med 1999; 27:2028-30.
30. Banks BA, Ischiropoulos H, McClelland M, Ballard PL, Ballard RA. Plasma 3-nitrotyrosine is elevated in premature infants who develop bronchopulmonary dysplasia. Pediatrics 1998; 101:870-4.
31. Lamb NJ, Gutteridge JMC, Baker C, Evans TW, Quinlan GJ. Oxidative damage to proteins of bronchoalveolar lavage fluid in patients with acute respiratory distress syndrome: evidence for neutrophil-mediated hydroxylation, nitration, and chlorination. Crit Care Med 1999; 27: 1738-44.
32. Lamb NJ, Quinlan GJ, Westerman ST, Gutteridge JMC, Evans TW. Nitration of proteins in bronchoalveolar lavage fluid from patients with acute respiratory distress syndrome receiving inhaled nitric oxide. Am J Respir Crit Care Med 1999; 160:1031-4.
33. Gole MD, Souza JM, Choi I, et al. Plasma proteins modified by tyrosine nitration in acute respiratory distress syndrome. Am J Physiol Lung Cell Mol Physiol 2000; 278:L961-7.
34. Beers MF, Bates SR, Fisher AB. Differential extraction for the rapid purification of bovine surfactant protein B. Am J Physiol 1992; 262: L773-8.
35. Wali A, Beers MF, Dodia C, Feinstein SI, Fisher AB. ATP and adenosine 3′,5′-cyclic monophosphate stimulate the synthesis of surfactant protein A in rat lung. Am J Physiol 1993; 264:L431-7.
36. Shellito JE, Suzara VV, Blumenfeld W, Beck JM, Steger HJ, Ermak TH. A new model of Pneumocystis carinii infection in mice selectivity depleted of helper T lymphocytes. J Clin Invest 1990; 85:1686-93.
37. + lymphocytes in host defense against Pneumocystis carinii in mice. J Lab Clin Med 1996; 128:477-87.
38. Beck JM, Liggit HD, Brunette EN, Fuchs HJ, Shellito JE, Debs RJ. Reduction in intensity of Pneumocystis carinii pneumonia in mice by aerosol administration of gamma interferon. Infect Immun 1991; 59: 3859-62.
39. Rudmann DG, Preston AM, Moore MW, Beck JM. Susceptibility to Pneumocystis carinii in mice is dependent on simultaneous deletion of IFN-γ and type 1 and 2 TNF receptor genes. J Immunol 1998; 161: 360-6.
40. Haczku A, Atochina EN, Tomer Y, et al. The late asthmatic response is linked with increased surface tension and reduced surfactant protein B in mice. Am J Physiol Lung Cell Mol Physiol 2002; 283:L755-65.
41. Atochina EN, Beers MF, Scanlon ST, Preston AM, Beck JM. P. carinii induces selective alterations in component expression and biophysical activity of lung surfactant. Am J Physiol Lung Cell Mol Physiol 2000; 278:L599-609.
42. Atochina EN, Beck JM, Scanlon ST, Preston AM, Beers MF. Pneumocystis carinii pneumonia alters expression and distribution of lung collectins SP-A and SP-D. J Lab Clin Med 2001; 137:429-39.
43. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72:248-54.
44. Bartlett GR. Phosphorous assay in column chromatography. J Biol Chem 1959; 234:466-8.
45. Gow AJ, McClelland M, Garner SE, Malcolm S, Ischiropoulos H. The determination of nitrotyrosine residues in proteins. Methods Mol Biol 1998; 100:291-9.
46. Ischiropoulos H, Beers MF, Ohnishi ST, Fisher D, Garner S, Thom SR. Nitric oxide production and perivascular tyrosine nitration in brain following carbon monoxide poisoning in the rat. J Clin Invest 1996; 97:2260-7.
47. Lorch SA, Foust R, Gow A, et al. Immunohistochemical localization of protein 3-nitrotyrosine and S-nitrosocysteine in a murine model of inhaled nitric oxide therapy. Pediatr Res 2000; 47:798-805.
48. Fang KZ, Ragsdale NV, Carey RM, Macdonald T, Gaston B. Reductive assays for S-nitrosothiols: implications for measurements in biological systems. Biochem Biophys Res Commun 1998; 252:535-40.
49. Limper AH, O'Riordan DM, Vuk-Pavlovic Z, Crouch EC. Accumulation of surfactant protein D in the lung during Pneumocystis carinii pneumonia. J Eukaryot Microbiol 1994; 41:98S.
50. LeVine AM, Whitsett JA, Hartshorn KL, Crouch EC, Korfhagen TR. Surfactant protein D enhances clearance of influenza A virus from the lung in vivo. J Immunol 2001; 167:5868-73.
51. Madan T, Kishore U, Singh M, et al. Protective role of lung surfactant protein D in a murine model of invasive pulmonary aspergillosis. Infect Immun 2001; 69:2728-31.
52. van Rozendaal BA, van Spriel AB, van de Winkel JG, Haagsman HP. Role of pulmonary surfactant protein D in innate defense against Candida albicans. J Infect Dis 2000; 182:917-22.
53. Hickling TP, Bright H, Wing K, et al. A recombinant trimeric surfactant protein D carbohydrate recognition domain inhibits respiratory syncytial virus infection in vitro and in vivo. Eur J Immunol 1999; 29: 3478-84.
54. Wright TW, Gigliotti F, Finkelstein JN, McBride JT, An CL, Harmsen AG. Immune-mediated inflammation directly impairs pulmonary function, contributing to the pathogenesis of Pneumocystis carinii pneumonia. J Clin Invest 1999; 104:1307-17.
55. Shellito JE, Kolls JK, Olariu R, Beck JM. Nitric oxide and host defense against Pneumocystis carinii infection in a mouse model. J Infect Dis 1996; 173:432-9.
56. Beck JM, Preston AM, Wagner JG, et al. Interaction of rat Pneumocystis carinii and rat alveolar epithelial cells in vitro. Am J Physiol 1998; 275: L118-25.
57. Fisher JH, Larson J, Cool C, Dow SW. Lymphocyte activation in the lungs of SP-D null mice. Am J Respir Cell Mol Biol 2002; 27:24-33.
58. Gaston B, Sears S, Woods J, et al. Bronchodilator S-nitrosothiol deficiency in asthmatic respiratory failure. Lancet 1998; 351:1317-9.
59. Grasemann H, Gaston B, Fang KZ, Paul K, Ratjen F. Decreased levels of nitrosothiols in the lower airways of patients with cystic fibrosis and normal pulmonary function. J Pediatr 1999; 135:770-2.